$3.14
0.07[2.28%]
At close: May 9
$3.14
0[0.00%]
After Hours: 5:47PM EDT
MEI Pharma
(NASDAQ:MEIP)Latest News for MEI Pharma Stock (NASDAQ:MEIP)
MEI Pharma Stock (NASDAQ: MEIP)
Categories: All
Thursday, May 09, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
Monday, February 19, 2024
Tuesday, February 13, 2024
Thursday, January 18, 2024
Monday, January 08, 2024
Monday, December 11, 2023
Thursday, November 16, 2023
Thursday, November 09, 2023
Monday, November 06, 2023
Wednesday, November 01, 2023
Tuesday, October 17, 2023
Friday, October 13, 2023
Monday, October 02, 2023
Wednesday, September 27, 2023
Tuesday, September 26, 2023
- MEI Pharma Q4 Adj EPS $(1.51), Sales $1.46M Beat $930.00K EstimateBenzinga Newsdesk - Sep 26, 2023, 4:47PM
- MEI Pharma Stockholders Anson And Cable Car File Definitive Consent Materials To Remove Entire Company Board for CauseBenzinga Newsdesk - Sep 26, 2023, 4:03PM
- 10% Owner of MEI Pharma Purchased $219K In StockBenzinga Insights - Sep 26, 2023, 11:02AM
- 329K Reasons To Be Bullish On MEI Pharma StockBenzinga Insights - Sep 26, 2023, 11:01AM
- Earnings Scheduled For September 26, 2023Benzinga Insights - Sep 26, 2023, 5:34AM
Monday, September 25, 2023
Monday, September 18, 2023
Wednesday, August 16, 2023
Tuesday, August 15, 2023
Thursday, July 27, 2023
Monday, July 17, 2023
Monday, July 10, 2023
Tuesday, June 27, 2023
- MEI Pharma Encouragea Shareholders Not To Be Confused By Anson And Cable Car's Latest Press ReleaseBenzinga Newsdesk - Jun 27, 2023, 5:17PM
- Anson Funds, Cable Car Capital Issue Statement Regarding Proposed Transaction Between MEI Pharma And Infinity PharmaceuticalsBenzinga Newsdesk - Jun 27, 2023, 9:27AM
Tuesday, June 13, 2023
Wednesday, June 07, 2023
Friday, June 02, 2023
Thursday, June 01, 2023
- Anson Funds Says "We Believe The Board's Outright Rejection Of Our Acquisition Proposal, Without Any Effort To Engage With Us, Represents A Complete Derogation Of Its Fiduciary Duties To The Company's Stockholders..."Happy Mohamed - Jun 1, 2023, 4:27PM
- Anson Funds And Cable Car Capital, Which Collectively Own 14.8% Of MEI Pharma, Inc., Have Issued A Statement In Response To The Rejection Of Their Acquisition Proposal To Acquire All Outstanding Shares Of MEIP For $8/ShareHappy Mohamed - Jun 1, 2023, 4:25PM
- MEI Pharma Board Of Directors Rejects Unsolicited Proposal; Concluded That The Unsolicited Proposal Significantly Undervalues The CompanyHappy Mohamed - Jun 1, 2023, 8:14AM
Tuesday, May 30, 2023
- MEI Pharma Confirms Receipt Of Unsolicited Acquisition ProposalBenzinga Newsdesk - May 30, 2023, 5:42PM
- On May 23, 2023, Anson Funds Management Delivered A Letter To The Chairman Of MEI Pharma Proposing To Acquire All Outstanding Shares Of MEI Not Already Held By Their Respective Funds For Not Less Than $8.00/Share, Plus A CVRCharles Gross - May 30, 2023, 5:21PM
Tuesday, May 23, 2023
- Clinical Triumph: MEI Pharma's Voruciclib Demonstrates Encouraging Activity in AML PatientsVandana Singh - May 23, 2023, 2:49PM
- Brookline Capital Maintains Buy on MEI Pharma, Announces $80 Price TargetBenzinga Newsdesk - May 23, 2023, 12:14PM
- Watching MEI Pharma; Hearing Brookline Capital Reiterates Buy Rating, $80 Price TargetBenzinga Newsdesk - May 23, 2023, 11:47AM
- MEI Pharma Updates On Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell MalignanciesBenzinga Newsdesk - May 23, 2023, 8:07AM